View in EDS PDF Full Text

Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.

Saved in:
Bibliographic Details
Title: Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
Authors: Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Brais L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Johnson S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Harrod J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Burman SSR; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Hendrickson LM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Fischinger S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America., Hahn W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Broad Institute of Harvard and MIT, Cambridge, MA, United States of America., Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America.
Source: PloS one [PLoS One] 2022 Apr 12; Vol. 17 (4), pp. e0266791. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35413078
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meyerhardt+JA%22">Meyerhardt JA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Yue+H%22">Yue H</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Nowak+RP%22">Nowak RP</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Brais+L%22">Brais L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Ma+C%22">Ma C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Johnson+S%22">Johnson S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Harrod+J%22">Harrod J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Burman+SSR%22">Burman SSR</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Hendrickson+LM%22">Hendrickson LM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Fischinger+S%22">Fischinger S</searchLink>; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Alter+G%22">Alter G</searchLink>; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Hahn+W%22">Hahn W</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Broad Institute of Harvard and MIT, Cambridge, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Johnson+BE%22">Johnson BE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Fischer+ES%22">Fischer ES</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2022 Apr 12; Vol. 17 (4), pp. e0266791. <i>Date of Electronic Publication: </i>2022 Apr 12 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35413078
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0266791
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0266791
    Titles:
      – TitleFull: Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meyerhardt JA
      – PersonEntity:
          Name:
            NameFull: Yue H
      – PersonEntity:
          Name:
            NameFull: Nowak RP
      – PersonEntity:
          Name:
            NameFull: Brais L
      – PersonEntity:
          Name:
            NameFull: Ma C
      – PersonEntity:
          Name:
            NameFull: Johnson S
      – PersonEntity:
          Name:
            NameFull: Harrod J
      – PersonEntity:
          Name:
            NameFull: Burman SSR
      – PersonEntity:
          Name:
            NameFull: Hendrickson LM
      – PersonEntity:
          Name:
            NameFull: Fischinger S
      – PersonEntity:
          Name:
            NameFull: Alter G
      – PersonEntity:
          Name:
            NameFull: Hahn W
      – PersonEntity:
          Name:
            NameFull: Johnson BE
      – PersonEntity:
          Name:
            NameFull: Fischer ES
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 04
              Text: 2022 Apr 12
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1